Whitney & Co’s Exact Sciences EXAS Stock Holding History

Whitney & Co’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-58	Closed	-$4K	–	216
2018 Q3	$4K	Buy	58 +13	+29%	+$848	﹤0.01%	410
2018 Q2	$3K	Hold	45	–	–	﹤0.01%	288
2018 Q1	$2K	Buy	+45	New	+$2.19K	﹤0.01%	291

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Whitney & Co's EXAS Position: Q4 2018 in Review

Whitney & Co sold out of Exact Sciences (EXAS) in Q4 2018, closing a stake of 58 shares — an estimated $4K sold.

Whitney & Co first reported a position in EXAS in Q1 2018 and held it in 3 quarters. The position peaked at $4K in Q3 2018. 370 funds tracked by Wall St. Rank hold EXAS as of Q4 2018.

Whitney & Co reported no remaining Exact Sciences position as of Q4 2018 after selling out during the quarter.
Whitney & Co sold 58 Exact Sciences shares in Q4 2018, an estimated $4K.
Whitney & Co first reported a position in Exact Sciences in Q1 2018 and held it in 3 quarters.
Whitney & Co's Exact Sciences position peaked at $4K in Q3 2018.
370 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2018.

Based on Whitney & Co's 13F filing for Q4 2018, filed 7 Feb 2019.